For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Lentinan is a beta-glucan (a type of polysaccharide) from the mushroom lentinus edodes (shiitake mushroom). It has been studied in Japan as a treatment for cancer.
Scope of the Report:
This report focuses on the Lentinan in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
As an intravenous biological response modifier, lentinan features potent antitumor effects, remarkably prolonged life, improved life quality and mild side effects. First developed by Japan, lentinan was approved to enter China in 1988. Although the practical use has confirmed lentinan's efficacy, its market size has been limited due to its high price. After entering the 21st century, lentinan has become able to be produced domestically at a relatively low price. Therefore, its market size grows at an increasing rate. Now, China is the dominate producer of lentinan, the production is 84528 Kg in 2015, according for about 67.85% of the total amount, followed by Japan, with the production market share of 15.72%. China also has the highest production growth rate of 6.00% from 2011 to 2015. Even though a huge space for growth in the Chinese market exists, the quality and technology should further improve.
The worldwide market for Lentinan is expected to grow at a CAGR of roughly 3.7% over the next five years, will reach 11 million US$ in 2023, from 9 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Panjin Gerun Biotech
- Golden Horizon Biologics
- Acetar Bio-Tech
- Johncan Mushroom Bio-technology
- Xi'an Changyue Phychemistry
- Xi'an Yuansun Biological
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Food Grade
- Pharmaceutical Grade
Market Segment by Applications, can be divided into
- Food additive
- Health product field
- Anti-cancer drug
There are 15 Chapters to deeply display the global Lentinan market.
Chapter 1, to describe Lentinan Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Lentinan, with sales, revenue, and price of Lentinan, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Lentinan, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Lentinan market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Lentinan sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source